Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 13, 2015 7:34 PM ET


Company Overview of KoRa Corporation Ltd

Company Overview

KoRa Corporation Ltd., doing business as KoRa Healthcare, develops, manufactures, and markets feminine health, sexual health, pediatric food, medical nutrition, and renal nutrition products, as well as point of care tests. It offers Relactagel to restore and maintain the natural acidity of the vagina, relieve abnormal vaginal discharge and odor, treat and prevent bacterial vaginosis, and use during pregnancy; Condyline to treat condylomata acuminata affecting the penis or female genitalia; Baby D, an oral solution of vitamin D3 (Cholecalciferol) for babies; and Magnaspartate for the dietary management of magnesium deficiency. The company also provides Renapro for the dietary management of di...

Swords Business Park



Founded in 1994


353 1 890 0406


353 1 890 3016

Key Executives for KoRa Corporation Ltd

Managing Director, Chairman of The Board for Immdal Limited and Managing Director of Immdal Limited
Compensation as of Fiscal Year 2015.

KoRa Corporation Ltd Key Developments

MeMediGene AG and Kora Healthcare Sign Agreement for the Commercialisation of Veregen in United Kingdom and Ireland

Medigene AG and Kora Healthcare concluded an exclusive agreement for the supply and commercialisation of Veregen(R) for the treatment of genital warts in United Kingdom and Ireland. Following marketing authorisation, Kora Healthcare will promote and distribute the drug for the treatment of genital warts. Medigene will receive a one-time upfront payment, revenues from milestone payments and from the supply of the finished product, as well as royalties on the future sales of Veregen(R) in the two countries.

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KoRa Corporation Ltd, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at